Peter Moore

pulmonary/CC @ University of Colorado / National Jewish

[WesternTrauma @WesternTrauma]

Happening *NOW*!! Paper 22: Coagulation Factor XIII: An Unrecognized Regulator of Fibrinolytic Phenotypes in Trauma @MoorePeterK @ChrisBarrettMD @HBuMoore @CU_PSCCM #WTA2025 #fellowshipofthesnow

[Peter Moore @MoorePeterK]

Plasminogen Degradation by Neutrophil Elastase in Pleural Infection, Not High Plasminogen Activator Inhibitor 1, Is the Cause of Intrapleural Lytic Failure - CHEST https://t.co/gk0khuHSnq
@ChrisBarrettMD @HBuMoore

[AJP-Lung Cellular and Molecular Physiology @AJPLung]

Moore et al. show during LPS-induced #inflammation, there are distinct populations of interstitial macrophages with unique functions. Folate Receptor β+ IMs = stable resident population. FRβ- ΙΜs = mixed population of resident & recruited IMs https://t.co/iUK4lo6b0Z
@MoorePeterK

[Peter Moore @MoorePeterK]

@rabihmgeha @CPSolvers Listening to some old friends in their element.

[Peter Moore @MoorePeterK]

@rabihmgeha @DxRxEdu Hypocomplementemic urticarial vasculitis and Incipient (talc) lung disease come to mind

[Peter Moore @MoorePeterK]

@yuvarajsingh94 @rabihmgeha Meliodosis, nocardia, ulcerative colitis

[Peter Moore @MoorePeterK]

@rabihmgeha @DxRxEdu Cobalt toxicity- personal experience with toxicity related to coating of a prosthetic joint 😔

[Peter Moore @MoorePeterK]

@scott_matson @DenPulm Power stance

[Peter Moore @MoorePeterK]

@rabihmgeha @DxRxEdu I would add pulm htn to vascular, obesity to increased A-a (microatelectasis) and neuromuscular to normal A-a (when hypoventilation from low Vt causes hypoxemia). Not sure how crazy you want to get with filled alveoli: lymphocytes, eosinophils, lipid, protein, calcium

[Peter Moore @MoorePeterK]

@WrayCharles Literally almost had to do this today and was trying to figure out if we needed to supinate first... very timely. Thanks

[Journal of the American College of Surgeons (JACS) @acsJACS]

Testing for blood clotting abnormalities reveals which critically ill COVID-19 patients are at risk for thrombotic events and need hemodialysis.
https://t.co/tYlgc6GdLx
#ACSCOVID19 #COVID19surgery
@AmCollSurgeons

[Ivor Douglas, MD @IvorDouglasMD]

‘If not me, who?’ Denver ICU doctors talk about treating COVID-19 patients https://t.co/CnEWHk7Kls

[Christopher Barrett M.D. @ChrisBarrettMD]

FDA just issued our IND to start our Phase 2 multi-center RCT of tPA in COVID respiratory failure! Finally!! Stay tuned...

[Peter Moore @MoorePeterK]

@sargsyanz Quality of life is a meaningful outcome that this would surely increase

[Judith Simcox PhD @JudithSimcox]

The NIH is looking for volunteers to quantify undetected cases of the coronavirus. They will send you an at-home blood collection kit and you can send it back to them to see if you have antibodies to the virus. Consider registering

https://t.co/tpJmAZymaO

[Victor Tseng @VectorSting]

Wrong question: "Should we treat #COVID19 like ARDS or not?"

A (slightly) better question: "What is the prevailing microvascular phenotype that will guide the best treatment for our patient's respiratory failure?" A work in progress with @RogerAlvarezDO:

[Neil deGrasse Tyson @neiltyson]

Let’s Make America Smart Again

[Peter Moore @MoorePeterK]

@rabihmgeha @k_vaishnani This is awesome Rabih! Idiopathic pulmonary hemosiderosis is tricky to categorize- I agree that vasculopathy is most accurate but may be inflammatory as steroids are the mainstay of treatment and it is associated with autoimmune diseases (like celiac)

[Peter Moore @MoorePeterK]

@KerryWard10 https://t.co/jWABgb6dJK

[Peter Moore @MoorePeterK]

@anna_neumeier @DenPulm Thats why I turn my video off during our Tuesday meetings...